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Heavy alcohol consumption is a known risk factor for various forms of dementia
and the development of Alzheimer’s disease (AD). In this work, we investigated
how intragastric alcohol feeding may alter the liver-to-brain axis to induce and/
or promote AD pathology. Four weeks of intragastric alcohol feeding to mice,
which causes signiﬁcant fatty liver (steatosis) and liver injury, caused no changes
in AD pathology markers in the brain [amyloid precursor protein (APP),
presenilin], except for a decrease in microglial cell number in the cortex of
the brain. Interestingly, the decline in microglial numbers correlated with serum
alanine transaminase (ALT) levels, suggesting a potential link between liver injury
and microglial loss in the brain. Intragastric alcohol feeding signiﬁcantly affected
two hepatic proteins important in amyloid-beta (Aβ) processing by the liver: 1)
alcohol feeding downregulated lipoprotein receptor-related protein 1 (LRP1,
~46%), the major receptor in the liver that removes Aβ from blood and
peripheral organs, and 2) alcohol signiﬁcantly upregulated APP (~2-fold), a
potentially important source of Aβ in the periphery and brain. The decrease in

Abbreviations: Aβ, amyloid-beta; AD, Alzheimer’s disease; ALT, alanine transaminase; APP, amyloid
precursor protein; LRP1, lipoprotein receptor-related protein 1; NAFLD, non-alcoholic fatty liver
disease; PSE1, presenilin 1; PSE2, presenilin 2; SYP, synaptophysin
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hepatic LRP1 and increase in hepatic APP likely switches the liver from being a
remover or low producer of Aβ to an important source of Aβ in the periphery,
which can impact the brain. The downregulation of LRP1 and upregulation of
APP in the liver was observed in the ﬁrst week of intragastric alcohol feeding,
and also occurred in other alcohol feeding models (NIAAA binge alcohol model
and intragastric alcohol feeding to rats). Modulation of hepatic LRP1 and APP
does not seem alcohol-speciﬁc, as ob/ob mice with signiﬁcant steatosis also
had declines in LRP1 and increases in APP expression in the liver. These ﬁndings
suggest that liver steatosis rather than alcohol-induced liver injury is likely
responsible for regulation of hepatic LRP1 and APP. Both obesity and
alcohol intake have been linked to AD and our data suggests that liver
steatosis associated with these two conditions modulates hepatic LRP1 and
APP to disrupt Aβ processing by the liver to promote AD.
KEYWORDS

amyloid precursor protein, lipoprotein receptor-related protein 1, liver, alcohol,
Alzheimer’s disease, beta-amyloid

Introduction

induced liver injury disrupts this axis, the brain may become
more susceptible to AD pathology. This may be true regarding
Aβ homeostasis, where the liver is involved in Aβ clearance from
blood and peripheral organs (Ghiso et al., 2004; Tamaki et al.,
2006; Wang et al., 2017; Bassendine et al., 2020), but is also a
potential source for Aβ in the periphery and blood, which can
ultimately accumulate in the brain (Sutcliffe et al., 2011; Lam
et al., 2021). The liver contains several receptors that have been
shown to bind to Aβ including lipoprotein receptor-related
protein 1 (LRP1), receptor for advanced glycation end
products (RAGE), and P-glycoprotein (Mohamed and
Kaddoumi, 2013; Yamagishi and Matsui, 2015). LRP1 appears
to be the most important receptor for peripheral Aβ clearance in
the liver (Zlokovic et al., 2010), as suppression of hepatic
LRP1 causes a 64% decline in Aβ uptake by the liver (Tamaki
et al., 2006). Since Aβ can be transported across the blood-brain
barrier by RAGE, hepatic LRP1 levels have been shown to
strongly affect plasma- and brain-Aβ levels (Zlokovic et al.,
2010; Sehgal et al., 2012). On the other hand, the liver, like
most organs, contains APP, which can form Aβ that is released
into circulation following the action of secretases such as
presenilin 2 (PSE2). A mutated form of PSE2 that promotes
AD has been shown to be heritable in the liver, but not in the
brain of mice (Sutcliffe et al., 2011). A liver speciﬁc
overexpression of human APP in mice has been shown to
increase Aβ levels in the periphery and the brain, as well as
promote AD pathology (Lam et al., 2021). Thus, key hepatic
proteins such as LRP1, PSE2, and APP may determine Aβ
processing and homeostasis in the liver, which profoundly
affects Aβ levels in the periphery and brain.
In this study, we examined the effect of alcohol on proteins
involved in the pathogenesis of AD in both the brain and liver
using different alcohol feeding models, including the intragastric
alcohol feeding model (Han et al., 2012; Han et al., 2017). While
several studies have examined the effects of alcohol feeding on

Heavy alcohol consumption is a known risk factor for various
forms of dementia and the development of Alzheimer’s disease
(AD) (Fratiglioni et al., 1993; Heymann et al., 2016). Alcohol
consumption may be an important modiﬁable risk factor for AD,
but the underlying factors linking alcohol consumption and AD
have not been conclusively identiﬁed. Most studies have largely
focused on the direct action of alcohol on the brain, and have
identiﬁed some alcohol-induced changes that may contribute to
AD. Alcoholism is associated with atrophy or loss of volume in
various areas of the brain including the cortex and hippocampus
(De La Monte et al., 1988; Sullivan et al., 1995; Mann et al., 2001).
Chronic alcohol feeding (oral alcohol diet) to mice has been
shown to increase the expression of amyloid precursor protein
(APP) and β-site amyloid precursor protein cleaving enzyme
(BACE) in select areas of the brain including the cerebellum,
hippocampus, and striatum (Kim et al., 2011). Alcohol feeding to
double transgenic Alzheimer’s mice (APP23/PS45) has also been
shown to increase APP expression in the brain (Huang et al.,
2018). Finally, binge alcohol exposure (2–4 days binge) in rats
has been shown to cause microglial dystrophy and decrease their
number in the hippocampus and perirhinal and entorhinal
cortices (Marshall et al., 2020). Taken together, these data
suggests that alcohol consumption can have various effects on
the brain that may promote AD.
While alcohol has many effects on the brain, chronic alcohol
consumption most directly damages the liver, which manifests as
alcoholic steatosis (fatty liver), hepatitis (inﬂammation plus fatty
liver), and cirrhosis (ﬁbrosis due to signiﬁcant hepatocyte death).
The liver performs many functions that are essential for brain
health, including: metabolic homeostasis, secretion of key plasma
proteins, and clearance of waste or excess biological products
such as amyloid-β (Aβ) (Ghiso et al., 2004; Wang et al., 2017).
This liver-brain axis is vital to brain health, and if alcohol-
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maltose dextrin solution (wt/vol) by oral gavage. Mice were
anesthetized with a lethal dose of Euthasol (150 mg/kg, IP) ~
9 h following the bolus dose of alcohol, and serum was collected
for ALT measurements. Cardiac perfusion was performed using
ice-cold phosphate buffer saline (PBS). Brains were harvested,
and hemi-brains were ﬁxed in 4% paraformaldehyde (PFA) for
immunostaining or were frozen in dry ice for Western blotting.

AD pathology in the brain, most of these studies have relied on
oral alcohol feeding models, which only cause modest liver
injury, and have not examined changes in the liver that may
promote AD pathology. This work focuses on whether a liver-tobrain axis may play a signiﬁcant role in alcohol-dependent AD.

Materials and methods
Ob/ob mice
All animal studies were performed under protocols approved
by the University of Southern California or Chapman University,
Institutional Animal Care and Use Committees.

Ob/ob, C57BL/6J, and C57BL/6NJ mice were obtained from
Jackson Laboratory (Bar Harbor, ME, United States) at 6 weeks
of age. All mice were fed standard chow (ad libitum) for up to
20 weeks (n = 5–6). The mice received care according to methods
approved under institutional guidelines for the care and use of
laboratory animals in research. C57BL/6J mice (6J mice),
background for ob/ob mice also harbor another mutation that
inactivates nicotinamide nucleotide transhydrogenase (NNT), a
mitochondrial protein on the inner membrane responsible for
transferring reducing equivalents from NADH to NADPH
(Garcia et al., 2018). C57BL/6NJ mice (6NJ mice), contain
functional NNT proteins and were used as an additional
control for ob/ob mice.

Animals
Intragastric alcohol feeding to mice and rats
Male C57BL/6J mice (~8 weeks of age) were obtained from
Jackson Laboratory (Bar Harbor, ME), whereas Wistar rats
(150 g, ~6 weeks) were obtained from Charles River
(Wilmington, MA). The animals were housed in a
temperature-controlled room and were acclimatized for a
minimum of 3 days prior to use in experiments. Intragastric
alcohol feeding to mice and rats was performed by the Southern
California Research Center for ALPD and Cirrhosis. Mice and
rats were implanted with a long-term gastrostomy catheter for
alcohol infusion or control diet as previously described (Han
et al., 2012; Han et al., 2017). Brieﬂy, after 1 week of
acclimatization, mice and rats were infused with a control diet
with or without alcohol. Alcohol infusion was initiated at a dose
of 22.7 g/kg/day, and gradually increased. Alcohol accounted for
~32.9% of total caloric intake after 1 week of intragastric alcohol
feeding. By 4 weeks of intragastric alcohol feeding, the caloric
intake of alcohol accounted for ~38.4% of total caloric intake.
Mice were fed alcohol intragastrically for 4 weeks, while rats were
fed intragastrically for 6 weeks. All animals received care
according to the methods approved under institutional
guidelines for the care and use of laboratory animals in
research. Blood was obtained after mice were anesthetized at
the indicated time periods, and serum alanine transaminase
(ALT) was assessed using a kit from MilliporeSigma (St.
Louis, MO, United States). Since intragastric alcohol feeding
requires mice to be attached to a catheter (limiting their mobility)
and are regularly intoxicated, AD cognitive test could not be
performed in this model.

Brain cryosectioning
For the intragastric- and NIAAA-binge-alcohol feeding
models, the right-cerebral hemi-brain of each mouse was
immersion-ﬁxed with 4% PFA in PBS for 24 h, followed by
serial incubation in 10%, 20%, and 30% sucrose solution at
4°C for 24 h each, and subsequently frozen. The frozen brain
tissues were mounted in Tissue-Tek OCT compound (Fisher
Scientiﬁc, MA, United States), and sliced into 20 μm-thick
sagittal sections at −25°C using a cryostat (Micron
Instruments, CA, United States). Three sections (600 µm
apart) per mouse were used for immunostaining as described
below (Ou et al., 2021).

Iba-1 immunostaining and quantiﬁcation
Free-ﬂoating sagittal brain sections were washed three times
for 2 min in PBS and blocked with 0.5% bovine serum albumin
(BSA) in PBS containing 0.3% Triton X-100 (TX100) for 60 min
at room temperature. Tissue sections were incubated with 0.5 μg/
ml anti-Iba-1 rabbit antibody (to detect microgliosis) in PBS
containing 0.3% TX100 and 0.5% BSA overnight at 4°C. After
washing, the tissue sections were incubated in the dark with 0.1%
AlexaFluor 488 donkey anti-rabbit IgG (Biolegend; CA,
United States) in PBS containing 0.3% TX-100 and 0.5% BSA
for 2 h at room temperature, washed, and mounted onto glass
slides, coverslipped with Vectamount aqueous mounting media
(Vector Laboratories, CA, United States), and sealed with nail

NIAAA binge alcohol feeding to mice
Male C57BL/6J mice (~8 weeks of age) were given alcohol via
the NIAAA binge model as previously described (Bertola et al.,
2013). Brieﬂy, mice were pair fed liquid alcohol diet (n = 6) or
control liquid diet [maltose dextrin—Bio-Serv (Flemington, NJ,
United States)] (n = 4) for 10 days. On the 11th day, mice were
given a bolus dose of 31.5% ethanol solution (vol/vol) or 45%
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polish. Slides were stored at 4°C until imaging. The ﬂuorescent
staining in the cortex and the hippocampus was analyzed using a
Leica TCS SP5 Confocal Microscope (Leica, NJ, United States),
by imaging two regions in the cortex and one region in the
hippocampus. The number of microglia were manually counted
in each image using the NIH ImageJ (version 1.53e, MD,
United States) for microglia number quantiﬁcation. For each
brain region, the microglia counts were averaged to give the
average number of microglia per region per mouse. The
overall number of microglia represents the average of the
microglia in the cortex and hippocampus. All NIH ImageJ
analysis was performed by two readers blinded to the
experimental groups.

TABLE 1 List of primer sequences used in study.

Direction

Sequence

β-actin

Forward

CAT TGC TGA CAG GAT GCA GAA GG

LRP1

LRP1-v2

APP

Reverse

TGC TGG AAG GTG GAC AGT GAG G

Forward

CGA GAG CCT TTG TGC TGG ATG A

Reverse

CGG ATG TCC TTC TCA ATG AGG G

Forward

GAC GTG CAA AGA TTT TGA CGA G

Reverse

AGC AGG TAG CCT TCA ACA CAG

Forward

TCC GTG TGA TCT ACG AGC GCA T

Reverse

GCC AAG ACA TCG TCG GAG TAG G

8%–12% SDS polyacrylamide gels (Biorad, Hercules, CA).
Subsequently, proteins were transferred to nitrocellulose or
PVDF membranes and blots were blocked with 5% (w/v)
nonfat milk dissolved in Tris-buffered saline (TBS) with
Tween-20. Antibodies to LRP1 (cat #64099), APP (cat
#76600), Presenilin 1 (cat #5643), Presenilin 2 (cat #9979),
GSK (cat #5676), and actin (cat #3700) were obtained from
Cell Signaling Technology. The antibody to synaptophysin (SYP;
sc-17750) was obtained from Santa Cruz Biotechnology (Dallas,
Texas). Densitometry was performed using ImageJ program
from NIH and normalized with actin as loading controls.

Histological analysis of liver
Livers were removed, ﬁxed with 10% buffered formalin,
embedded in parafﬁn, and cut into 5-μm thick sections. All
specimens were stained with hematoxylin/eosin (Η&Ε) by the
Histology Core at the USC Center for Liver Diseases and were
evaluated under a light microscope.

Brain homogenization and mouse Aβ
(1–42) ELISA

Real-time quantitative PCR

The frozen left cerebral hemisphere without the
cerebellum was pulverized to a ﬁne homogeneous powder
on dry ice, which was homogenized in ﬁve volumes of
TPER with Roche complete EDTA-free Mini protease
inhibitor by a mechanical homogenizer (Waverly, IA) and
rotated at 4°C for 1 h. The homogenate was centrifuged at
14,000 × g for 20 min at 4°C and the supernatant was aliquoted
and stored at −80°C for ELISA or immunoblotting. An aliquot
of the supernatant was set aside to measure protein
concentration using a bicinchoninic acid kit (Pierce
Chemical Co., Rockford, IL). A part of the brain and liver
homogenate supernatants and plasma samples were used for
the detection of mouse Aβ (1–42) using a sandwich ELISA kit
no. KMB3441 (Thermo Fisher Scientiﬁc, Waltham, MA).
Absorbance (OD) was measured at 450 nm. Standard curves
were ﬁt to a four-parameter logistic regression curve and the
tissue Aβ (1–42) levels were calculated and normalized based
on the total protein amount in the tissue samples.

LRP1, APP, and actin mRNA levels in the liver were
assessed by RT-PCR (Table 1). RNA was extracted from
liver following homogenization using column based
isolation (PureLink RNA Mini Kit, Invitrogen). RNA was
quantiﬁed using Tecan NanoQuant Inﬁnite 200 Pro, and
matched to a concentration of 50 ng of RNA. cDNA was
then reverse transcribed using Invitrogen SuperScript III
First-Strand Synthesis SuperMix (utilizing Oligo (dT)) and
thermocycler. cDNA was subsequently diluted to 1:10 with
RNase-free water. For RT-PCR, 2 µL of this dilution was used
per well in conjunction with 12.5 µL SYBR Green (Applied
Biosystems PowerSYBR Green PCR Master Mix), 9.5 µL
RNase-free water, and 1 µL of mixed forward and reverse
primer (Integrated DNA Technologies - Coralville, Iowa) at
a concentration of 10 μM, for a total of 25 µL per well. Nontemplate controls were used to test for primer contamination
and/or primer-dimer interactions. To assess primer validity, a
standard curve was conducted to ensure efﬁciency percentages
were between 90% and 110%. Samples were loaded into a
96 well plate with each condition run in triplicate. A Roche
Lightcycler 96 was set for a preincubation cycle of 10 min at
95°C, followed by 40 cycles of 2-step ampliﬁcation at 95°C for
15 s and 60°C for 60 s, and ﬁnally a melting curve of 95°C for
15 s, 65°C for 15 s, and a ramp towards 95°C increasing at a

Immunoblotting
For immunoblotting, livers were homogenized in RIPA
buffer (Thermo Scientiﬁc #89900) containing protease/
phosphatase inhibitor cocktail (Cell Signaling Technology,
Danvers, MA, cat #5872). Protein electrophoresis occurred on
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FIGURE 1
Effect of intragastric alcohol feeding on AD-relevant alterations in the brains of mice. (A) Expression of APP, PSE1, PSE2, LRP1, and
synaptophysin (SYN), proteins that are involved in Aβ synthesis, transport, and neuronal health, respectively, following 4 weeks of intragastric alcohol
feeding to mice. All immunoblots shown are representative samples from ﬁve experiments. Densitometry for APP and LRP1 in the brain was
performed using NIH ImageJ. β-actin was used as the loading control. (B) Microglial numbers (Iba-1-stained cells) in the brain following 4 weeks
of intragastric alcohol feeding. The images show Iba-1-stained cells in the cortex and hippocampus (scale bar represents 50 µm). Each Iba-1-stained
image was manually read to count the number of microglia per image using NIH ImageJ. For each brain region, the microglia counts were averaged
to give the average number of microglia per region per mouse. n = 6–7 mice per group. Results are mean ± SD. **p < 0.01. Original blots are
presented in Supplementary Figures.

speed of 0.2°C per second. The resulting Cq data was collected
from Roche’s Lightcycler 96 SW 1.1 software and was averaged
and analyzed using the 2−ΔΔCT method. In order to assess
differences imposed by ethanol consumption on LRP1 and
APP transcription, we reverse transcribed RNA isolated from
liver homogenate, and conducted RT-PCR on the resultant
cDNA. Interestingly, several standard genes tested as controls
displayed some degree of variation between ethanol and
control groups (including GAPDH, HPRT1, SRSF4, and
TBP), with β-actin appearing most stable. Consequently, βactin was chosen as control.

Correlation analysis was performed using the Pearson
correlation r. A two-tailed p < 0.05 was deﬁned as statistically
signiﬁcant.

Results
Effect of intragastric alcohol feeding on
AD-relevant alterations in the brains of
mice
We ﬁrst examined the effect intragastric alcohol feeding
had on important proteins involved in Aβ production and
transport, synaptic health, and microgliosis, which are
dysregulated in AD brains (Crews and Masliah, 2010). No
signiﬁcant changes were observed in the protein levels of APP,
LRP1, PSE1, PSE2, and synaptophysin (SYP), a synaptic
protein that has been reported to decline in AD
(Figure 1A). However, interestingly 4 weeks of intragastric

Statistical analysis
Numerical data is presented as mean ± SD, and all the
statistical analysis was performed using GraphPad Prism 9
(GraphPad Software Inc., CA). Two-sample t test or ANOVA
with repeated measures were performed when appropriate.
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FIGURE 2
Effect of intragastric alcohol feeding on liver injury and its relationship with microglial number in the brain. (A) Hematoxylin and eosin (H&E)
histology of mice liver following 4 weeks of intragastric alcohol feeding (×200 magniﬁcation). The arrows point to lipid droplets in the liver associated
with steatosis. Representative samples of intragastric alcohol fed and control mice are shown. (B) ALT levels in serum following 4 weeks of
intragastric alcohol feeding to mice. n = 6–7 mice. Results are mean ± SD. (C) Scatter plot showing the relationship between liver injury (ALT
levels) and microglial number in the brain. ****p < 0.0001, **p < 0.01, or *p < 0.05 vs. control.

greater the decline in microglial numbers with alcohol
feeding was observed (Figure 2C).
In the liver, intragastric alcohol feeding signiﬁcantly
affected two important proteins associated with Aβ
synthesis and transport: APP and LRP1 (Figure 3A). APP
levels in the liver increased by ~97% (p < 0.01) with
intragastric alcohol feeding, while LRP1 levels in the liver
declined by ~46% (p < 0.01) as determined by
immunoblotting. The levels of glycogen synthase kinase-3
(GSK) in the liver were not signiﬁcantly altered with
intragastric alcohol feeding. This increase in APP and
decline in LRP1 in the liver with intragastric alcohol
feeding was also observed by RT-qPCR (Figure 3B). The
decline in LRP1 expression in ethanol fed mice was
consistent across two selected primer sequences, with
respective decreases of 27% (p < 0.05) and 34% (p < 0.05)
compared to control animals. APP mRNA expression
increased by ~120% (p < 0.01) with alcohol feeding
(Figure 3B), levels very similar to those observed with
immunoblotting (Figure 3A). The changes in LRP1 and
APP expression induced by alcohol were early events in
intragastric alcohol feeding, as signiﬁcant decline in
LRP1 and APP was observed even at 2- and 4-weeks of
intragastric alcohol feeding (Figure 3C).

alcohol feeding was associated with a signiﬁcant decline in
number of microglial cells (Iba-1stained cells) in the cortex
(p < 0.01) and in the cortex and hippocampus combined (p <
0.01) (Figure 1B). Microglial cells in the hippocampus also
experience a decline, but that decline was not statistically
signiﬁcant.

Effect of intragastric alcohol feeding on
AD-relevant alterations in the livers of
mice
We next examined the effect of intragastric alcohol feeding
on important proteins involved in Aβ production and
transport in the liver, the major site of alcohol-induced
injury. In agreement with our previously published results,
4 weeks of intragastric alcohol feeding caused extensive fatty
liver (steatosis) (Figure 2A) and signiﬁcantly increased ALT
levels (marker of hepatocyte death) in the plasma (Figure 2B).
A possible connection between liver injury and the brain was
observed, as ALT levels were negatively correlated with
microglial numbers in the cortex (Pearson r = −0.58, p <
0.01) and cortex and hippocampus combined (Pearson
r = −0.50, p < 0.05). The greater the liver injury, the
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FIGURE 3
Effect of intragastric alcohol feeding on AD-relevant alterations in the liver of mice. (A) Expression of APP, LRP1, and other key proteins
important in Aβ synthesis and transport in the liver following 4 weeks of intragastric alcohol feeding to mice. (B) Expression of LRP1 and APP mRNA
following 4 weeks of intragastric alcohol feeding. LRP1 and LRP2-V2 represent two different primer variants that were examined by qPCR using SYBR
Green. β-actin was used as control, as it appeared most stable compared to other control genes examined. Data represents the mean ±
standard error, with n = 11–18 mice. Percent changes are calculated with 2−ΔΔCT. (C) Time course of LRP1 down regulation and APP up regulation in
the liver following intragastric alcohol. Mice were fed alcohol intragastrically for 1, 2, and 4 weeks. All immunoblots shown are representative samples
from four to six experiments. Densitometry for APP and LRP1 in the liver was performed using NIH Image J with β-actin being used as the loading
control. Results are mean ± SD. n = 7–10 mice. ****p < 0.0001, ***p < 0.001, **p < 0.01, or *p < 0.05 vs. control.

FIGURE 4
Mouse Aβ (1–42) levels in the brain, plasma, and liver following 4 weeks of intragastric alcohol feeding to mice. Levels of mouse Aβ (1–42)
in brain and liver homogenate supernatants, as well as plasma samples were determined using ELISA. Results are mean ± SD. n = 6–7 mice.
*p < 0.05 vs. control.

Frontiers in Physiology

07

frontiersin.org

Garcia et al.

10.3389/fphys.2022.930402

FIGURE 5
Effect of other alcohol feeding models on hepatic LRP1 and APP levels. The effect of the NIAAA binge model on liver injury and steatosis (A), in
addition to LRP1 and APP expression in the liver (B). ALT, H&E histology (×200 magniﬁcation), and immunoblotting of mice liver occurred following
NIAAA binge model (6 weeks oral alcohol feeding plus a binge). The arrows point to lipid droplets in the liver associated with steatosis. n = 4–6 mice.
The effect of intragastric alcohol feeding to rats on liver injury and steatosis (C), and hepatic LRP1 and APP expression in intragastric alcohol fed
rats (D). ALT, H&E histology, and immunoblotting of rat liver occurred following 6 weeks of intragastric alcohol feeding to rats (n = 5 rats).
Densitometry for APP and LRP1 in the liver was performed using NIH Image J with β-actin being used as the loading control. Results are mean ± SD.
***p < 0.001, **p < 0.01, or *p < 0.05 vs. control.

Mouse Aβ (1–42) levels in the brain,
plasma, and the liver following intragastric
alcohol feeding

in the body, Aβ (1–42) levels in brain, plasma, and liver were
measured using ELISA (Figure 4). In the brain and plasma, no
difference in Aβ (1–42) was observed after 4 weeks of intragastric
alcohol feeding, likely due to the short nature of the alcohol
feeding studies. In the liver, on the other hand, there was a
signiﬁcant increase in Aβ (1–42) (~61%, p < 0.05) suggesting that

To determine the effect of alcohol-induced downregulation
of hepatic LRP1 and upregulation of hepatic APP had on Aβ load
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Modulation of hepatic LRP1 and APP in the
ob/ob steatosis model

increased alcohol-induced expression of APP, could be causing
an increase in Aβ (1–42) production by the liver.

We next examined whether the downregulation of hepatic
LRP1 and upregulation of hepatic APP was alcohol speciﬁc or
due to liver pathology by investigating a non-alcohol model of
steatosis, ob/ob mice. These mice have spontaneously
developed a mutation in leptin, leading to increased food
intake, obesity, and steatosis (Sharma et al., 2010; Rull
et al., 2014). Ob/ob mice have even more steatosis than
intragastric alcohol fed mice (Figure 6A), which has been
well documented (Rull et al., 2014; Garcia et al., 2018). Ob/
ob mice had a comparable signiﬁcant decline in LRP1 (~45%
vs. 6J, ~60% vs. NJ, p < 0.05) similar to the levels observed in
the alcohol models and had a signiﬁcant increase in APP
(~59% vs. 6J, ~51% vs. NJ, p < 0.05), which was somewhat
lower than that observed with alcohol feeding models
(Figure 6B). These results suggest that changes in hepatic
LRP1 and APP are not solely due to alcohol, and that
steatosis may play a signiﬁcant role in the regulation of
these two proteins in the liver.

Effect of different alcohol models on
hepatic LRP1 and APP levels
The intragastric alcohol feeding model is the only method
that allows for delivery of high doses of alcohol to animals that
cause signiﬁcant steatosis (fatty liver) and liver injury, seen in
human alcoholic patients (Tsukamoto et al., 1985; Han et al.,
2017). Oral alcohol feeding models (i.e., Lieber-DeCarli diet)
which have been used in some rodent AD studies mainly produce
some steatosis and cause low-to-moderate liver injury
(Tsukamoto et al., 1985; Han et al., 2012; Han et al., 2017).
The NIAAA binge alcohol model has become more widely
utilized since it causes more liver injury and steatosis than
oral alcohol feeding models, though still signiﬁcantly less than
the intragastric model (Bertola et al., 2013). We examined if
alcohol feeding to mice using the NIAAA binge model also
modulated LRP1 and APP in the liver. Figure 5A shows that
the NIAAA binge model caused liver injury demonstrated by a
signiﬁcant elevation in ALT levels, although ALT levels were ~5fold lower than those observed with the intragastric alcohol
feeding. Liver steatosis was also observed with the NIAAA
binge model (Figure 5A), but generally at lower levels than
observed with the intragastric alcohol feeding as previously
discussed (Bertola et al., 2013). Although liver injury was
lower with the NIAAA binge model, the decline in LRP1
(~49%, p < 0.05) and increase in APP (~110%, p < 0.01) was
very similar to levels observed with the intragastric alcohol fed
mice (Figure 5B).
We also examined whether alcohol-induced changes to
hepatic LRP1 and APP levels were species speciﬁc by
investigating changes in these proteins in rats that were fed
alcohol intragastrically (Figures 5C,D). Rats are generally much
more resistant to alcohol-induced liver injury than mice, and
thus represents a different animal model of alcoholic liver disease
(Shinohara et al., 2010). In agreement with previous studies, rats
fed alcohol intragastrically had ~3-fold lower ALT levels than
mice fed alcohol intragastrically. Steatosis also appeared to be
lower in rats than mice, which has been explored in other studies
(Shinohara et al., 2010). Even though rats experienced less
alcohol-induced liver injury then mice, hepatic LRP1 levels
declined similarly to levels seen in mice (~53%, p < 0.05), and
APP expression increase was much more dramatic (~320%,
although with greater variability, p < 0.05). These results
suggest that alcohol-induced decline in LRP1 and increase in
APP was not species speciﬁc (occurring in both mice and rats) or
alcohol feeding-model speciﬁc (occurring in both intragastric
and oral NIAAA feeding models). Overall, alcohol-induced
changes to hepatic LRP1 and APP occurred within a wide
range of liver injury and steatosis.
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Discussion
The consumption of chronic alcohol is a known risk factor
for various forms of dementia and the development of AD
(Fratiglioni et al., 1993; Heymann et al., 2016). The main
hallmarks of AD are Aβ deposition, phosphorylated tau
containing neuroﬁbrillary tangles, neuronal loss and
microgliosis (Crews and Masliah, 2010). Accordingly,
utilizing the intragastric alcohol feeding model, the model
which can deliver highest amount of alcohol to mice and rats,
we studied the effect of alcohol consumption on proteins
involved in Aβ synthesis and transport, neuronal health,
and microgliosis. We observed that high levels of alcohol
feeding resulted in a signiﬁcant decline in the number of
microglial cells in the cortex. This ﬁnding is consistent with
an increase in dystrophic microglia and a reduction in the
number of microglia with alcohol consumption in rats
(Marshall et al., 2020). The implications of these ﬁndings
for AD can be signiﬁcant given the complex and
contrasting roles played by microglia (Leng and Edison,
2021). In the AD brain, microglia are found surrounding
Aβ plaques and microglial recognition of Aβ can trigger
microglial activation that can result in Aβ phagocytosis and
clearance (Sarlus and Heneka, 2017; Leng and Edison, 2021).
Additionally, these plaque-surrounding microglia were
recently shown to form a physical barrier around the Aβ
plaques protecting against neuronal damage (Spangenberg
et al., 2019). Therefore, a decrease in microglia with alcohol
feeding could impact Aβ and neuronal homeostasis in the
brain (Sarlus and Heneka, 2017; Hansen et al., 2018), and this
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FIGURE 6
Expression of LRP1 and APP in ob/ob steatosis mice. (A) Representative H&E histology (×200 magniﬁcation) of ob/ob mice liver and control
mice (J, NJ) at 20 weeks of age. The arrows point to lipid droplets in the liver associated with steatosis. (B) LRP1 and APP expression in the liver of ob/
ob with advance steatosis. n = 6 mice per group. 6J and 6NJ represent two different control mice for ob/ob mice. Results are mean ± SD; ****p <
0.0001, **p < 0.01, or *p < 0.05 vs. J or NJ controls.

been reported in previous oral or binge alcohol feeding studies
(Kim et al., 2011; Huang et al., 2018). Our work examined APP
and Aβ in total brain of wild-type mice, while other studies
used transgenic AD mice (APP23/PS45 mice) where human
APP and PSE1 are overexpressed (Huang et al., 2018) or
studied APP increase in speciﬁc regions of the brain
(cerebellum, hippocampus, and striatum), and not total
brain homogenates. It is quite possible that APP and/or Aβ
upregulation is brain-region speciﬁc following intragastric
alcohol feeding, and future work will be needed to
determine brain-region speciﬁc APP and Aβ expression
following intragastric alcohol feeding.
The most signiﬁcant ﬁnding of our work was that chronic
alcohol feeding or obesity causes a major decline in hepatic
LRP1 levels while substantially increasing hepatic APP levels.
These two changes are likely to have a signiﬁcant effect on hepatic
processing of Aβ, possibly altering the liver from being a remover
or minor source of Aβ to an important source of Aβ in the
periphery (Figure 7). The notion that the liver becomes an
important source of Aβ following steatosis is supported by the
following observations. First, liver speciﬁc overexpression of
human APP has been shown to increase Aβ levels in the
periphery and the brain to promote AD pathology in mice
(Lam et al., 2021). The human Aβ produced in the liver of
these transgenic mice was not observed in the brain of mice at
6 months of age, but became signiﬁcant at 1 year, suggesting it
takes a signiﬁcant amount of time for Aβ produced in the liver to
accumulate in the brain. A 2-fold increase in hepatic APP
expression observed in our studies following alcohol feeding is

idea is further supported by a reduction in Aβ phagocytosis by
alcohol-treated microglia (Kalinin et al., 2018). In contrast, Aβ
mediated microglial activation can also trigger cytokine
release and neuroinﬂammation, which can in turn increase
Aβ production through the upregulation of β-secretase (Sarlus
and Heneka, 2017; Leng and Edison, 2021). A decrease in
microglia with alcohol feeding can therefore also potentially
reduce neuroinﬂammation and Aβ production. Further
studies in transgenic mouse models of AD are needed to
gauge the exact impact of alcohol-induced decline of
microglial number on AD pathology. How alcohol reduces
microglial cell number in the brain remains unknown, but it
has been suggested that alcohol may be directly cytotoxic to
microglia (Marshall et al., 2020). Interestingly, we observed a
signiﬁcant inverse relationship between liver injury (ALT
levels) and microglial levels in the cortex; with greater liver
injury, there was a greater decline in microglial cell number.
This suggests a potential liver-brain axis regulating microglial
cells in the brain. Liver injury may trigger the release of various
toxins (e.g., reactive oxygen species, acetaldehyde), cytokines
that promote neuroinﬂammation, or other signaling
molecules that decrease microglial replication or promote
microglial apoptosis (Han et al., 2006; Venkataraman et al.,
2017). However, the possibility that liver injury and the
decline in microglial cells occurred concurrently due to
poorer capacity to metabolize alcohol or other factors
cannot be ruled out. With respect to endogenous APP and
endogenous mouse Aβ (1–42) expression, we did not observe
an increased expression of APP or Aβ in the brain, which had
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FIGURE 7
Model of Aβ processing by healthy and fatty liver. The liver plays a signiﬁcant role in determining Aβ load in the peripheral organs and blood, as
both a source of Aβ and by clearing Aβ. LRP1 in the liver has been identiﬁed as the major receptor responsible for Aβ clearance from the blood. Aβ
binding to LRP1 is believed to trigger endocytosis and uptake of Aβ inside hepatocytes, where it is degraded by lysosomes, and secreted in bile.
Modulation of LRP1 in the liver has been shown to affect the capacity of the liver to clear Aβ from the periphery. The liver also contains APP,
which through the action of secretases such as PSE2, can be cleaved to Aβ causing its release into circulation. A healthy liver is likely to consume or
produce low levels of Aβ, unless there are genetic mutations such as PSE2 mutations. In the case of fatty liver (steatosis), our work demonstrates that
LRP1 levels are inhibited by ~50% and APP expression is increased 2-fold. The decreased LRP1 and increased APP expression during liver steatosis
likely makes the liver an important source of Aβ in the blood and liver, which can increase Aβ levels in the brain to promote AD. Created with
BioRender.com.

while its upregulation by the root extract Withania somnifera
(WS) was shown to decrease plasma- and brain-Aβ levels and
improve cognitive function in aged AD mice (Sehgal et al., 2012).
LRP1 expression in the liver has been shown to signiﬁcantly
decline with age, which also corresponded with decline in Aβ
clearance by the liver (Tamaki et al., 2006).
The fact that both alcohol feeding models (intragastric to
mice and rats, NIAAA binge) and obesity caused the
downregulation of LRP1 and upregulation of APP suggests
that steatosis may be the uniting factor in the dysregulation of
these two genes in the liver. In support of this notion, gene
proﬁling of non-alcoholic fatty liver disease (NAFLD) patients
showed that APP gene expression in the liver was increased (Qi
et al., 2017). In another study, high fat diet feeding to wild-type
and AD transgenic mice (APP-Tg) was found to decrease
LRP1 levels in the brain, however, the LRP1 levels in the liver
were not examined (Kim et al., 2016). However, ob/ob mice and
NAFLD are associated with some increases in ALT and liver
injury, so the distinction between liver injury and steatosis in the
regulation of hepatic LRP1 and APP may be difﬁcult to untangle.
Liver steatosis is a disease associated with aberrant lipid
metabolism involving many signaling pathways including
transcription factors such as p63 and stress signaling
including activation of JNK (Win et al., 2021; Da Silva Lima
et al., 2022). The lipid droplets and fatty acids associated with

similarly likely to increase Aβ production by the liver, but likely
would take time to make a signiﬁcant impact in the periphery and
brain. Consequently, we only observed increases in Aβ levels in
the liver, and not in the plasma or brain following alcohol
feeding, probably due to the short duration of our studies.
Unfortunately, it is very difﬁcult to perform lengthy alcohol
feeding studies in animals, but further studies examining
steatosis caused by high fat feeding on hepatic Aβ production
are being performed.
In addition to upregulation of APP, the downregulation of
LRP1 associated with steatosis is likely to signiﬁcantly impact the
ability of the liver to clear Aβ from the periphery (Tamaki et al.,
2006; Zlokovic et al., 2010). Previous studies have demonstrated a
link between hepatic function and peripheral Aβ clearance, with
liver injury being associated with elevated peripheral Aβ in
patients (Wang et al., 2017). The mechanism of how liver
injury could affect Aβ clearance has not been identiﬁed. Our
data suggests that a 50% decline in hepatic LRP1 expression
associated with alcohol feeding and in ob/ob mice may explain
the previously observed relationship between hepatic function
and Aβ clearance. LRP1 has been demonstrated to be the major
receptor in the liver involved in the clearance of Aβ from the
periphery (Tamaki et al., 2006; Zlokovic et al., 2010; Mohamed
and Kaddoumi, 2013). Suppression of hepatic LRP1 has been
shown to decrease Aβ uptake by the liver (Tamaki et al., 2006),
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dementia and the development of AD (Fratiglioni et al., 1993;
Heymann et al., 2016). Similarly, obesity, particularly in midlife,
is a well-characterized risk factor for the development of AD
(Whitmer et al., 2008; Gustafson et al., 2012). Previous studies
attempting to characterize the link between alcohol and obesity
have primarily focused on the brain. Our work shows that the
liver may also play a very important role in the pathology of AD
caused by obesity and chronic alcohol intake. We found that liver
injury (ALT levels) was inversely correlated with microglia
numbers suggesting a possible liver-brain crosstalk. We also
demonstrate that liver steatosis triggers a decline in
LRP1 expression, while simultaneously increasing APP
expression in the liver. These changes likely decrease the
liver’s capacity to take up Aβ from the periphery and enhance
its potential to produce Aβ and promote AD.

liver steatosis in turn can affect many signaling pathways
including insulin signaling to promote diabetes mellitus type
II (Shannon et al., 2021). Thus, signaling pathways involved in
triggering steatosis and signaling pathways altered by lipid
accumulation during steatosis could be involved in regulation
of LRP1 and APP. The alcohol-induced signaling pathways that
modulate hepatic APP and LRP1 occurred within 1 week of
intragastric alcohol feeding, suggesting it is an early event
with alcohol feeding. More detailed time course experiments
are needed to determine when hepatic APP and LRP1 signaling
pathways are modulated by alcohol in the various models.
LRP1 has been shown to be regulated by various signaling
pathways including SREBP2, Sp1/3, and PPARγ (Gauthier et al.,
2003; Costales et al., 2010; Aledo et al., 2014). SREBP2 may play a
key role in the downregulation of hepatic LRP1 during alcohol
feeding. Chronic alcohol feeding has been shown to activate
SREBP2 (cleavage and translocation to the nucleus) in the liver
(Ji et al., 2006), and SREBP2 has been shown to bind to the SRE
sequence located in the 5′-UTR of LRP1 and downregulate its
expression (Llorente-Cortes et al., 2007; Costales et al., 2010).
qPCR data shows only a 27%–34% decline in LRP1 mRNA
expression, suggesting the ~50% decline in LRP1 protein
expression may also be due to translational or posttranslational changes. LRP1 in the liver has been shown to be
cleaved by proteases such as BACE (Von Arnim et al., 2005). It is
possible that soluble LRP1 (sLRP1) in plasma, a peripheral “Aβsink,” may originate from the liver following cleavage by
proteases (Sagare et al., 2007). The post-translational
modiﬁcation of LRP1 in liver may contribute to the reduction
of LRP1 that occurs with steatosis, which requires further
investigation. The promoter for APP has binding sites for a
number of transcription factors, including a heat shock control
element, SP-1, AP-1, and AP-4 sites (Salbaum et al., 1988;
Quitschke and Goldgaber, 1992). In HeLa cells, alcohol
treatment and other stressors (e.g., temperature, sodium
arsenite) have been shown to upregulate APP expression
through activation of heat shock elements (Dewji et al., 1995;
Dewji and Do, 1996). A similar mechanism of heat shock factors
enhancing APP transcription in the liver following alcohol
treatment may also be occurring. Other transcriptional factors
such as AP-1 may also play a role in upregulation of APP
observed in our studies, as AP-1 activation has been shown to
play an important role in liver steatosis (Hasenfuss et al., 2014).
Clearly, further studies will be needed to characterize the
signaling pathways that modulate hepatic LRP-1 and APP in
alcohol-induced and obesity-induced liver steatosis.
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Conclusion
Alcohol and obesity are two conditions known to cause
steatosis in the liver and have also been linked to AD. Heavy
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